YD Bio Limited Ordinary Shares (YDES) Stock
Key stats
- Market cap
- $435.68M
- Price / Earnings ratio
- 1396.1x
- EPS (TTM)
- -$0.12
- Volume
- Loading
- 52-week high
- $15.72
- 52-week low
- $1.70
Source: third-party data provider, as of November 13, 2026
Compare with YDES
Technical indicators
- RSI 14
- 51.25
- MACD 12/26/9
- 0.22
- EMA 9 of MACD
- 0.24
- MACD histogram
- -0.02
- SMA 50
- $5.46
- Price above SMA 50
- EMA 50
- $5.53
- Price above EMA 50
- SMA 200
- $5.30
- Price above SMA 200
- EMA 200
- $6.37
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
About YD Bio Limited Ordinary Shares
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Ethan Shen Ph.D. | CEO & Chairman | 1977 |
| Dr. Benjamin Zhang M.D. | Chief Medical Officer & Director | 2000 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 51.25
- MACD 12/26/9
- 0.22
- EMA 9 of MACD
- 0.24
- MACD histogram
- -0.02
- SMA 50
- $5.46
- Price above SMA 50
- EMA 50
- $5.53
- Price above EMA 50
- SMA 200
- $5.30
- Price above SMA 200
- EMA 200
- $6.37
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +182.1 | -23.9 | +1.0 |




